Physician profile
Matthias Heinz Wiederholz
NPI 1336327279
$853,110.28
in general payments reported to CMS, 2019-2025
73 companies · $102K in 2025
The $102K reported for 2025 was more than what 99% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136K · 2020: $132K · 2021: $117K · 2022: $115K · 2023: $99K · 2024: $151K · 2025: $102K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $160K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $124K · Travel and Lodging: $45K · Food and Beverage: $23K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $159,899.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $123,980.00 |
| Travel and Lodging | $44,958.19 |
| Food and Beverage | $23,398.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $316,496.37 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Stimwave Technologies Incorporated | $236,785.69 | 2019-2022 | |
| Curonix LLC | $158,324.73 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic USA, INC. | $110,538.42 | 2019-2020 | |
| Zavation Medical Products, LLC | $5,963.33 | 2022-2025 | |
| Nevro Corp. | $5,596.87 | 2019-2024 | Senza, Vyrsa V1 |
| Abbott Laboratories | $4,648.68 | 2019-2025 | Proclaim, Eterna |
| Mml US, INC. | $3,515.11 | 2021-2023 | Reactiv8 |
| Stratus Medical, LLC | $1,389.06 | 2020-2022 | |
| Si-Bone, INC. | $1,072.94 | 2020-2024 | |
| Boston Scientific Corporation | $869.13 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $638.27 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $489.34 | 2021-2025 | Botox, Qulipta, Ubrelvy |
| Spinefrontier, INC. | $428.56 | 2021 | |
| Scilex Pharmaceuticals INC. | $420.98 | 2019-2024 | Ztlido |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $401.67 | 2019-2021 | |
| Tersera Therapeutics LLC | $371.60 | 2019-2024 | Prialt |
| Globus Medical, INC. | $358.31 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $326.25 | 2019-2025 | Relistor |
| Relievant Medsystems, INC. | $311.62 | 2019-2023 | Intracept |
| Vertos Medical, INC. | $301.07 | 2022-2024 | Mild Device Kit |
| Stryker Corporation | $276.96 | 2023-2025 | Optablate, Omnicurve, Spinejack |
| Biodelivery Sciences International, INC. | $219.19 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $174.13 | 2021-2025 | Xeomin |
| Pacira Pharmaceuticals Incorporated | $169.20 | 2020-2025 | Zilretta, Iovera, Exparel |
| Sentynl Therapeutics, INC. | $168.51 | 2019 | |
| Redhill Biopharma INC. | $163.24 | 2020-2022 | |
| Spr Therapeutics, INC | $153.97 | 2023 | Sprint Pns System |
| Avanos Medical | $149.25 | 2019 | |
| Allergan, INC. | $145.49 | 2019-2021 | |
| Lundbeck LLC | $141.46 | 2022-2025 | Vyepti |
| Vgi Medical, LLC | $125.55 | 2022 | |
| Pfizer INC. | $123.65 | 2019-2024 | |
| Depuy Synthes Sales INC. | $122.32 | 2019-2024 | Orthovisc, Monovisc |
| Biotronik Nro, INC. | $104.73 | 2023-2025 | Prospera, Biotronik |
| Teva Pharmaceuticals USA, INC. | $93.44 | 2019-2020 | |
| Lilly USA, LLC | $88.32 | 2019-2024 | Emgality |
| Novartis Pharmaceuticals Corporation | $84.35 | 2019-2021 | |
| Merz North America, INC. | $80.52 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $79.72 | 2025 | |
| Novo Nordisk INC | $76.18 | 2023-2024 | Wegovy |
| Ibsa Pharma INC. | $75.17 | 2022-2023 | Tirosint, Licart |
| Bioventus LLC | $71.95 | 2021-2024 | Durolane, Durolane |
| Axonics, INC. | $63.09 | 2023 | Axonics, Bulkamid |
| Nalu Medical, INC. | $50.79 | 2021-2023 | Nalu Neurostimulation System |
| Painteq LLC | $48.47 | 2023-2024 | Painteq |
| Orthogenrx INC. | $45.32 | 2019 | |
| Zimmer Biomet Holdings, INC. | $44.30 | 2024-2025 | Gel-One Cross-Linked Hyaluronate |
| Daiichi Sankyo INC. | $43.67 | 2019 | |
| Eisai INC. | $43.50 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $42.96 | 2019-2021 | |
| Interventional Pain Technologies INC. | $41.48 | 2022 | |
| Saluda Medical Americas, INC. | $41.35 | 2024-2025 | Evoke |
| Fidia Pharma USA INC. | $40.00 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $33.80 | 2021 | |
| Valinor Pharma, LLC | $31.62 | 2024 | Movantik |
| Virtus Pharmaceuticals LLC | $31.10 | 2021 | |
| Acella Pharmaceuticals, LLC | $30.99 | 2024-2025 | NP Thyroid 60 |
| Amgen INC. | $30.39 | 2025 | Evenity |
| Baxter Healthcare | $29.93 | 2025 | Tisseel |
| Vertiflex, INC. | $29.93 | 2019 | |
| International Rehabilitative Sciences, INC | $28.88 | 2023-2024 | Rs 4i Plus Sequential Stimulator |
| Almatica Pharma LLC | $28.10 | 2022-2023 | Gralise |
| Epimed International, INC | $26.18 | 2024 | Needles and Catheters |
| Electronic Waveform Lab, INC. | $24.28 | 2021 | |
| Spinal Simplicity, LLC | $23.53 | 2023 | Ha Minuteman G3-R |
| Elutia, INC. | $20.57 | 2019 | |
| Assertio Therapeutics, INC. | $20.16 | 2019 | |
| Grt US Holding, INC. | $19.68 | 2020 | |
| Mdd US Operations, LLC | $17.58 | 2020 | |
| Idorsia Pharmaceuticals US INC | $16.80 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $13.69 | 2021 | |
| Myoscience INC. | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthias Wiederholz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.